ARUP's Laboratory Test Directory

Hepatitis C Virus Antibody (RIBA), Supplemental : 0020104

Mnemonic: HCVAB RIBA

Methodology: Recombinant Immunoblot Assay
Performed: Wed-Sat
Reported: 1-5 days
Specimen Required: Collect:  One 4 mL serum separator tube.

Transport:  1 mL serum at 2-8°C. (Min: 0.5 mL) Submit specimen
in an ARUP Standard Transport Tube.

Submit specimen according to Biological Substance, Category B, shipping guidelines.


Pediatric Collection/Transport:  0.1 mL serum at 2-8°C.

Submit specimen according to Biological Substance, Category B, shipping guidelines.


Remarks:  EDTA or citrated plasma is also acceptable.  Separate serum or plasma from cells ASAP.

Stability:  After separation from cells: Ambient: Up to 1 week is acceptable, but not preferred; Refrigerated: 1 week; Frozen: Indefinitely (avoid repeated freeze/thaw cycles)
Reference Interval:
Negative
Interpretive Data: ARUP intends use of this assay for clinical diagnosis.  This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular and Tissue-Based Products (HCT/P).
Note: Recombinant immunoblot assay (RIBA) is recommended for specimens with low positive anti-HCV screening results. For high positive anti-HCV screening results, ARUP recommends collecting a new specimen and testing for hepatitis C RNA by PCR or bDNA.
CPT Code(s): 86804
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org